IPARInter Parfums, Inc.
The schedule
- Thu15Oct
Market evaluation of President Trump's trade policies and their impact on IPAR's European-sourced fragrance portfolio.
- Tue3Nov
Q3 2026 earnings announcement focusing on organic revenue growth against potential margin compression.
- Tue12Jan
Mid-quarter update on holiday sell-through metrics at major global retailers and travel retail channels.
- Tue2Feb
Q4 2026 earnings print and the critical issuance of FY2027 revenue and EPS forward guidance.
- Thu15Apr
Strategic update on new brand licensing agreements and potential M&A integration milestones.
- Tue4May
Q1 2027 results reflecting the early momentum of newly integrated brand licenses.
- Tue3Aug
Past
- Tue15Sep
Assessment of IPAR's early fall fragrance rollout and sell-in strength for new prestige brand extensions.
- Tue4Aug
Actual outcome: Bull
Interparfums reported a 2% year-over-year increase in Q2 sales to $341 million, driven by gains in North America, Asia Pacific, and Latin America, though earnings missed estimates due to higher marketing and logistics costs. Despite the bottom-line miss, the stock reacted positively because management confidently reaffirmed its full-year sales and earnings guidance. This reassurance of full-year targets, combined with resilient top-line growth successfully offsetting regional weaknesses in Europe and the Middle East, drove the bullish market response.
Q2 2026 earnings announcement. Investors will look for momentum in the prestige fragrance market and updates on key brand licenses.
- Tue10Mar
Actual outcome: Bull · $104.20 at outcome
Price reached or exceeded bull target ($100.00) at outcome date.
Price reached or exceeded bull target ($100.00) at outcome date.
